Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: Influence of patient-related variables

作者: Antonio Lucacchini , Claudia Martini , Liliana Dell'Osso , Lionella Palego , Luciano Biondi

DOI: 10.1016/S0278-5846(01)00291-3

关键词:

摘要: Abstract Steady-state plasma concentrations of clozapine and norclozapine, its major metabolite, as well their sum ratio (norclozapine/clozapine), were evaluated in 50 in- outpatients taking naturalistically recruited. Drug measured by means a reversed-phase high-performance liquid chromatography (RPLC) method with an ultraviolet detection. Daily doses (milligrams per kilogram body weight) correlated positively parameters, except the norclozapine/clozapine ratio, all patients. When patients divided subgroups respect to gender, corresponding no longer dose-related men. A lack significant correlation was observed also ( n =23) co-treated typical neuroleptics. Conversely, dose–concentration correlations either smoker or nonsmoker No relationship between weight parameters reported. Further, we (1) trend towards higher medians total analytes women than those reported men P =.09 .07); (2) difference levels obtained subjects younger 34 years old older; (3) norclozapine plus =.05 .08) patients; (4) co-medicated neuroleptics receiving alone.

参考文章(40)
Eric C. Dessain, Jonathan O. Cole, P. E. Keck, Harrison G. Pope, Susan L. McElroy, H. G. Aizley, S. O'Brien, F. R. Frankenberg, Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. The Journal of Clinical Psychiatry. ,vol. 52, pp. 411- 414 ,(1991)
Jose Ma. J. Alvir, Jeffrey A. Lieberman, Allan Z. Safferman, Jeffrey L. Schwimmer, John A. Schaaf, Clozapine-induced agranulocytosis. Incidence and risk factors in the United States The New England Journal of Medicine. ,vol. 329, pp. 162- 167 ,(1993) , 10.1056/NEJM199307153290303
Ereshefsky L, Tran-Johnson Tk, Watanabe, Clozapine: an atypical antipsychotic agent. Clinical pharmacy. ,vol. 8, pp. 691- 709 ,(1989)
Jeffrey R Schein, Cigarette Smoking and Clinically Significant Drug Interactions Annals of Pharmacotherapy. ,vol. 29, pp. 1139- 1148 ,(1995) , 10.1177/106002809502901113
M. Tohen, M. D. Banov, J. O. Cole, C. A. Zarate, M. K. Weiss, Is clozapine a mood stabilizer The Journal of Clinical Psychiatry. ,vol. 56, pp. 108- 112 ,(1995)
A Burkhart, A Franke, H Bräu, W Pacha, M Ackenheil, [Antipsychotic efficacy in relation to plasma levels of clozapine (author's transl)]. Drug Research. ,vol. 26, pp. 1156- 1158 ,(1976)
Influence of patient-related variables on clozapine plasma levels. American Journal of Psychiatry. ,vol. 147, pp. 1471- 1475 ,(1990) , 10.1176/AJP.147.11.1471
Joseph R Calabrese, Susan E Kimmel, Mark J Woyshville, Daniel J Rapport, Carl J Faust, Paul A Thompson, Herbert Y Meltzer, Clozapine for Treatment-Refractory Mania American Journal of Psychiatry. ,vol. 153, pp. 759- 764 ,(1996) , 10.1176/AJP.153.6.759
Stephen M. Stahl, Antipsychotic Polypharmacy, Part 1: Therapeutic Option or Dirty Little Secret? The Journal of Clinical Psychiatry. ,vol. 60, pp. 425- 426 ,(1999) , 10.4088/JCP.V60N0701